Henry Wilke Murray, M.D.
Dr. Murray has published 211 original research and clinical publications and review articles, 9 invited editorials and 64 books and book chapters. Recent selected publications include:
Murray HW. State-of-the-Art: Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 71:787, 2004.
Murray HW. Interleukin 10 receptor blockade-pentavalent antimony treatment in experimental visceral leishmaniasis. Acta Tropica 93:295, 2005.
Murray HW, Flanders KC, Donaldson DD, et al. Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. Infect Immun 73:3903, 2005.
Murray HW. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. J. Immunol. 174:4916, 2005.
Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 366:1561, 2005.
Sundar S, Maurya R, Singh RK, Bharti K, Chakravarty J, Parekh A, Rai M, Kumar K,
Murray HW. Rapid noninvasive diagnosis in Indian visceral leishmaniasis: comparison of two strips formats in detection of anti-K39 antibody. J Clin Microbiol 44:251, 2006.
Murray HW, Xiang Z, Ma X. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase. Am J Trop Med Hyg 74:1013, 2006.
Murray HW, Tsai CW, Liu J, Ma X. Responses to Leishmania donovani in mice deficient in IL-12, IL-12/IL-23 or IL-18. Infect Immun 74:4370, 2006.
Murray HW, Tsai CW, Liu J, Ma X. Visceral Leishmania donovani infection in IL-13-/- mice. Infect Immun 74:2487, 2006.
Sundar S, Chakravarty J, Rai VK, Agrawal N, Singh SP, Chauhan V, Murray HW.
Amphotericin B treatment in Indian visceral leishmaniasis: response to 15 daily vs. alternate-day infusions. Clin Infect Dis 45:556, 2007.
Miro JM, Murray HW, Katlama C. Toxoplasmosis. In AIDS Therapy (eds. R. Dolin, H. Masur, M. Saag), Churchill Livingstone, Inc., 3rd Edition, New York, chapter 37, 2008
Sundar S, Rai M, Chakravarty J, Agrawal D, Agrawal N, Vaillant M, Olliaro P, Murray HW. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by with short-course miltefosine. Clin Infect Dis 47:1000, 2008.
Murray HW. Accelerated control of visceral Leishmania donovani infection in IL-6-/- mice. Infect Immun 76:4088, 2008.